COUNTY OF SANTA CLARA, Plaintiff-Appellant,
v.
ASTRA USA, INC.; AstraZeneca Pharmaceuticals LP; Aventis Pharmaceuticals, Inc.; Bayer Corporation; Bristol-Myers Squibb Company; Pfizer, Inc.; Schering-Plough Corporation TAP Pharmaceutical Products, Inc.; Zenecca Inc.; ZLB Behring LLC; SmithKline Beecham Corporation; SmithKline Beecham Corporation, dba GlaxoSmithKline; Wyeth, Inc.; Wyeth Pharmaceuticals, Inc., Defendants-Appellees.
United States Court of Appeals, Ninth Circuit.https://leagle.com/images/logo.png
Argued and Submitted March 11, 2008.
Filed August 27, 2008.
Attorney(s) appearing for the Case
Patrick J. Coughlin, Sanford Svetcov (argued), Jeffrey W. Lawrence, Jacqueline E. Mottek, Aelish M. Baig and Jennie Lee Anderson, Coughlin Stoia Geller Rudman & Robbins LLP, San Francisco, CA; Ann Miller Ravel, Cheryl A. Stevens and Tamara Lange, Santa Clara County Counsel's Office, San Jose, CA; Steve W. Berman and Douglas C. McDermott, Hagens Berman Sobol Shapiro LLP, Seattle, WA, for plaintiff-appellant County of Santa Clara.
Robert S. Litt (argued), Jeffrey L. Handwerker and Sharon Douglass Mayo, Arnold & Porter LLP, Washington, D.C., for defendants-appellees Astra USA, Inc., AstraZeneca Pharmaceuticals, LP and Zeneca Inc.; Alicia J. Donahue and Sara Romano, Shook, Hardy & Bacon LLP, San Francisco, CA, for defendants-appellees Aventis Pharmaceuticals, Inc. and ZLB Behring LLC; Timothy T. Scott, Geoffrey M. Ezgar and Paul Yanosy, Sidley Austin LLP, San Francisco, CA, for defendant-appellee Bayer Corporation; Paul J. Riehle and Matthew A. Fischer, Sedgwick Detert Moran & Arnold LLP, San Francisco, CA, for defendant-appellee Bristol-Myers Squibb Company; Federick G. Herold, Valerie M. Wagner and Philip Barilovits, Dechert LLP, Palo Alto, CA, for defendant-appellee SmithKline Beecham Corporation; Molly M. Lane and Tera Heinz, Morgan, Lewis & Bockius LLP, San Francisco, CA, for defendant-appellee Pfizer Inc.; Kirke M. Hasson and Colin T. Kemp, Pillsbury Winthrop Shaw Pittman LLP, San Francisco, CA, for defendant-appellee Schering-Plough Corporation; Peter N. Larson, Jones Day, San Francisco, CA, for defendant-appellee TAP Pharmaceutical Products, Inc.; Fletcher Alford, Gordon & Rees, LLP, San Francisco, CA, for defendants-appellees Wyeth, Inc. and Wyeth Pharmaceuticals Inc.
Before: STEPHEN REINHARDT, MELVIN BRUNETTI and RAYMOND C. FISHER, Circuit Judges.
United States Court of Appeals, Ninth Circuit.
FISHER, Circuit Judge:
Certain federally funded medical clinics — so-called "Section 340B covered entities" — are able to purchase prescription drugs at a discount from drug manufacturers under a standardized agreement between the federal government and the drug companies. During 2003, for example, these covered entities spent $3.4 billion on outpatient prescription drugs. They claim in this lawsuit that they have been overcharged for those drugs in...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.
